| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d6c95e8f0651bdac5c7e20e59ce1dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_218c5ade1b03b891b805504cbb5c97ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_984d555404845247bdb0f526ff625b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72acb1054b0bf4fad60a20900325e81a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-163 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C381-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C223-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C381-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C223-06 |
| filingDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2841ea06c2c93231dea3f9ff3f6cc46a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6cb4a112839cd44dc7946499a3b5b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bbf99906b541238c5ed779adff32432 |
| publicationDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019033297-A1 |
| titleOfInvention |
Compounds inhibiting nef-calnexin interaction |
| abstract |
The invention relates to compounds and methods for restoring or preserving cholesterol efflux in a cell infected with Human Immunodeficiency Virus (HIV) by preventing or decreasing an interaction between Negative Regulatory Factor (Nef) protein and Calnexin protein, and methods for screening for such compounds. |
| priorityDate |
2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |